Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 1, 2017, Pages 201-216

  Ighodaro, Eseosa T ^a   Abner, Erin L ^a,b   Fardo, David W ^a,b   Lin, Ai Ling ^a,c   Katsumata, Yuriko ^b   Schmitt, Frederick A ^a   Kryscio, Richard J ^a,b   Jicha, Gregory A ^a   Neltner, Janna H ^a   Monsell, Sarah E ^d   Kukull, Walter A ^d   Moser, Debra K ^e   Appiah, Frank ^b   Bachstetter, Adam D ^a   Van Eldik, Linda J ^a   Nelson, Peter T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF KENTUCKY COLLEGE OF NURSING   (United States)

Author keywords

Arteriosclerosis; CVD; HS Aging; TDP 43; VCID

Indexed keywords

ABCC9 GENE; AGED; ARTERIAL SPIN LABELING; ARTERIOLOSCLEROSIS; ARTICLE; BRAIN BLOOD FLOW; CEREBROVASCULAR DISEASE; CLINICAL OUTCOME; COGNITION; COGNITIVE FUNCTION TEST; CONTROLLED STUDY; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPAL SCLEROSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PRIORITY JOURNAL; RISK FACTOR; VERY ELDERLY; AGING; BRAIN; BRAIN CIRCULATION; COMPLICATION; FACTUAL DATABASE; GENETIC VARIATION; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY;

ABCC9 PROTEIN, HUMAN; SULFONYLUREA RECEPTOR;

AGED; AGED, 80 AND OVER; AGING; ARTERIOLOSCLEROSIS; BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION; DATABASES, FACTUAL; GENETIC VARIATION; HUMANS; HYPERTENSION; RISK FACTORS; SULFONYLUREA RECEPTORS;

EID: 85006356458     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X15621574     Document Type: Article

References (98)

1. Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002; 12: 358-370.
2. Roman GC and Benavent O. The neuropathology of vascular dementia. Seminars in Cerebrovascular Diseases and Stroke 2010; 4: 87-96.
3. Zheng L, Vinters HV, Mack WJ, et al. Cerebral atherosclerosis is associated with cystic infarcts and microin-farcts but not Alzheimer pathologic changes. Stroke 2013; 44: 2835-2841.
4. Esiri MM, Wilcock GK and Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997; 63: 749-753.
5. Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci 2013; 5: 17.
6. Erkinjuntti T, Benavente O, Eliasziw M, et al. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol 1996; 53: 325-332.
7. Pantoni L, Garcia JH and Brown GG. Vascular pathology in three cases of progressive cognitive deterioration. J Neurol Sci 1996; 135: 131-139.
8. Neltner JH, Abner EL, Baker S, et al. Arteriolosclerosis that affects multiple brain regions is linked to hippocam-pal sclerosis of ageing. Brain 2014; 137(Pt 1): 255-267.
9. Vinters HV, Ellis WG, Zarow C, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 2000; 59: 931-945.
10. Bridges LR, Andoh J, Lawrence AJ, et al. Blood-brain barrier dysfunction and cerebral small vessel disease (arter-iolosclerosis) in brains of older people. J Neuropathol Exp Neurol 2014; 73: 1026-1033.
11. Chou SH, Shulman JM, Keenan BT, et al. Genetic susceptibility for ischemic infarction and arteriolosclerosis based on neuropathologic evaluations. Cerebrovasc Dis 2013; 36: 181-188.
12. Buchman AS, Yu L, Boyle PA, et al. Microvascular brain pathology and late-life motor impairment. Neurology 2013; 80: 712-718.
13. Gavornik P and Galbavy S. Clinical picture of arteriolo-sclerosis. Bratisl Lek Listy 2001; 102: 326-331.
14. Grinberg LT and Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol 2010; 119: 277-290.
15. Baker AB. Structure of the small cerebral arteries in hypertension. Am J Pathol 1941; 17: 39-46.
16. Moritz AR and Oldt MR. Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 1937; 13: 679-728
17. Johnson G. 1. On certain points in the anatomy and pathology of Bright's Disease of the kidney. 2. On the influence of the minute blood-vessels upon the circulation. Med Chir Trans 1868; 51: 57-78.3.
18. Baumbach GL, Dobrin PB, Hart MN, et al. Mechanics of cerebral arterioles in hypertensive rats. Circulation Res 1988; 62: 56-64.
19. Baumbach GL, Sigmund CD and Faraci FM. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension 2003; 41: 50-55.
20. Rizzoni D, Porteri E, Guelfi D, et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 2001; 103: 1238-1244.
21. Schofield I, Malik R, Izzard A, et al. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002; 106: 3037-3043.
22. Danis RP and Yang Y. Microvascular retinopathy in the Zucker diabetic fatty rat. Invest Ophthalmol Visual Sci 1993; 34: 2367-2371.
23. Like AA, Lavine RL, Poffenbarger PL, et al. Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. Am J Pathol 1972; 66: 193-224.
24. Nelson PT, Estus S, Abner EL, et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathologica 2014; 127: 825-843.
25. Nelson PT, Wang WX, Partch AB, et al. Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology. J Neuropathol Exp Neurol 2015; 74: 75-84.
26. Nelson PT, Smith CD, Abner EL, et al. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta neuropathologica 2013; 126: 161-177.
27. Standen NB, Quayle JM, Davies NW, et al. Hyperpolarizing vasodilators activate ATP-sensitive K + channels in arterial smooth muscle. Science 1989; 245: 177-180.
28. Nelson PT, Abner EL, Schmitt FA, et al. Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol 2010; 20: 66-79.
29. Thal DR, Ghebremedhin E, Orantes M, et al. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 2003; 62: 1287-1301.
30. Toledo JB, Arnold SE, Raible K, et al. Contribution of cerebrovascular disease in autopsy confirmed neurode-generative disease cases in the National Alzheimer's Coordinating Centre. Brain 2013; 136(Pt 9): 2697-2706.
31. Folstein MF, Folstein SE and McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189-98.
32. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-2414.
33. Monsell SE, Mock C, Roe CM, et al. Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology. Neurology 2013; 80: 2121-2129.
34. Lynch CA, Walsh C, Blanco A, et al. The clinical dementia rating sum of box score in mild dementia. Dementia Geriatr Cogn Disord 2006; 21: 40-43.
35. Savva GM, Wharton SB, Ince PG, et al. Age, neuropath-ology, and dementia. N Engl J Med 2009; 360: 2302-2309.
36. von Gunten A, Ebbing K, Imhof A, et al. Brain aging in the oldest-old. Curr Gerontol Geriatr Res 2010. DOI:10.1155/2010/358531.
37. Imhof A, Kovari E, von Gunten A, et al. Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm? J Neurol Sci 2007; 257: 72-79.
38. Nelson PT, Head E, Schmitt FA, et al. Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol 2011; 121: 571-587.
39. Ubhi K, Peng K, Lessig S, et al. Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease. Neurosci Lett 2010; 485: 222-7.
40. Bancher C and Jellinger KA. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects. Acta neuropathologica 1994; 88: 565-570.
41. Lorke DE, Wai MS, Liang Y, et al. TUNEL and growth factor expression in the prefrontal cortex of Alzheimer patients over 80 years old. Int J Immunopathol Pharmacol 2010; 23: 13-23.
42. Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006; 20: 210-216.
43. Beekly DL, Ramos EM, van Belle G, et al. The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord 2004; 18: 270-277.
44. Brenowitz WD, Monsell SE, Schmitt FA, et al. Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both Alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. J Alzheimer's Dis 2014; 39: 691-702.
45. Weintraub S, Salmon D, Mercaldo N, et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord 2009; 23: 91-101.
46. Mueller SG, Weiner MW, Thal LJ, et al. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am 2005; 15: 869-877. xi-xii.
47. Mueller SG, Weiner MW, Thal LJ, et al. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimer's Dement 2005; 1: 55-66.
48. Braak H, Alafuzoff I, Arzberger T, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006; 112: 389-404.
49. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
50. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011; 43: 436-441.
51. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011; 43: 429-435.
52. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013; 45: 1452-1458.
53. Beekly DL, Ramos EM, Lee WW, et al. The National Alzheimer's Coordinating Center (NACC) database: the uniform data set. Alzheimer Dis Assoc Disord 2007; 21: 249-258.
54. Nelson PT, Pious NM, Jicha GA, et al. APOE-epsilon2 and APOE-epsilon4 correlate with increased amyloid accumulation in cerebral vasculature. J Neuropathol Exp Neurol 2013; 72: 708-715.
55. Leow AD, Klunder AD, Jack CR Jr, et al. Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. NeuroImage 2006; 31: 627-640.
56. Wang J, Alsop DC, Song HK, et al. Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med 2003; 50: 599-607.
57. Ramage AE, Lin AL, Olvera RL, et al. Resting-state regional cerebral blood flow during adolescence: associations with initiation of substance use and prediction of future use disorders. Drug Alcohol Depend 2015; 149: 40-48.
58. Brayne C, Richardson K, Matthews FE, et al. Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study. J Alzheimer's Dis 2009; 18: 645-658.
59. Ohm TG, Scharnagl H, Marz W, et al. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions. Acta Neuropathol 1999; 98: 273-280.
60. Dickson DW, Davies P, Bevona C, et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (>or=80 years of age) humans. Acta Neuropathol 1994; 88: 212-221.
61. Haneuse S, Schildcrout J, Crane P, et al. Adjustment for selection bias in observational studies with application to the analysis of autopsy data. Neuroepidemiology 2009; 32: 229-239.
62. Johnston DW, Propper C and Shields MA. Comparing subjective and objective measures of health: evidence from hypertension for the income/health gradient. J Health Econ 2009; 28: 540-552.
63. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220-2241.
64. Buchman AS, Leurgans SE, Nag S, et al. Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke 2011; 42: 3183-3189.
65. Deramecourt V, Slade JY, Oakley AE, et al. Staging and natural history of cerebrovascular pathology in dementia. Neurology 2012; 78: 1043-1050.
66. Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 2002; 16: 203-212.
67. Nelson PT, Jicha GA, Schmitt FA, et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neuro-fibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol 2007; 66: 1136-1146.
68. Furuta A, Ishii N, Nishihara Y, et al. Medullary arteries in aging and dementia. Stroke 1991; 22: 442-446.
69. Ferrer I, Bella R, Serrano MT, et al. Arteriolosclerotic leucoencephalopathy in the elderly and its relation to white matter lesions in Binswanger's disease, multi-infarct encephalopathy and Alzheimer's disease. J Neurol Sci 1990; 98: 37-50.
70. Desmond DW. The neuropsychology of vascular cogni-tive impairment: is there a specific cognitive deficit? J Neurol Sci 2004; 226: 3-7.
71. Lammie GA, Brannan F, Slattery J, et al. Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke 1997; 28: 2222-2229.
72. Nelson PT, Smith CD, Abner EA, et al. Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim Biophys Acta 2009; 1792: 454-469.
73. Nelson PT, Schmitt FA, Lin Y, et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 2011; 134(Pt 5): 1506-1518.
74. Zarow C, Weiner MW, Ellis WG, et al. Prevalence, lat-erality, and comorbidity of hippocampal sclerosis in an autopsy sample. Brain Behav 2012; 2: 435-442.
75. Leverenz JB, Agustin CM, Tsuang D, et al. Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. Arch Neurol 2002; 59: 1099-1106.
76. Crystal HA, Schneider JA, Bennett DA, et al. Associations of cerebrovascular and Alzheimer's disease pathology with brain atrophy. Curr Alzheimer Res 2014; 11: 309-316.
77. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyper-intensities. Neurology 1993; 43: 1683-1689.
78. Scheltens P, Barkhof F, Leys D, et al. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 1995; 45: 883-888.
79. Shim YS, Yang DW, Roe CM, et al. Pathological correlates of white matter hyperintensities on magnetic resonance imaging. Dement Geriatr Cogn Disord 2015; 39: 92-104.
80. Bal S, Goyal M, Smith E, et al. Central nervous system imaging in diabetic cerebrovascular diseases and white matter hyperintensities. Handb Clin Neurol 2014; 126: 291-315.
81. Erten-Lyons D, Woltjer R, Kaye J, et al. Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology 2013; 81: 977-983.
82. Oishi M and Mochizuki Y. Differences in regional cerebral blood flow in two types of leuko-araiosis. J Neurol Sci 1999; 164: 129-133.
83. Kobari M, Meyer JS and Ichijo M. Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging. Arch Neurol 1990; 47: 161-165.
84. Promjunyakul N, Lahna D, Kaye JA, et al. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures. NeuroImage Clin 2015; 8: 224-229.
85. Albert M, Massaro J, DeCarli C, et al. Profiles by sex of brain MRI and cognitive function in the Framingham offspring study. Alzheimer Dis Assoc Disord 2010; 24: 190-193.
86. Au R, Massaro JM, Wolf PA, et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol 2006; 63: 246-250.
87. Luchsinger JA, Brickman AM, Reitz C, et al. Subclinical cerebrovascular disease in mild cognitive impairment. Neurology 2009; 73: 450-456.
88. Williams LR, Hutchinson CE, Jackson A, et al. Clinical correlates of cerebral white matter hyperintensities in cognitively normal older adults. Arch Gerontol Geriatr 2010; 50: 127-131.
89. Silbert LC, Dodge HH, Perkins LG, et al. Trajectory of white matter hyperintensity burden preceding mild cognitive impairment. Neurology 2012; 79: 741-747.
90. Nichols CG, Singh GK and Grange DK. KATP channels and cardiovascular disease: suddenly a syndrome. Circ Res 2013; 112: 1059-1072.
91. Zhang HL and Bolton TB. Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells. Br J Pharmacol 1996; 118: 105-114.
92. Thorneloe KS, Maruyama Y, Malcolm AT, et al. Protein kinase C modulation of recombinant ATP-sensitive K(+) channels composed of Kir6.1 and/or Kir6.2 expressed with SUR2B. J Physiol 2002; 541(Pt 1): 65-80.
93. Yamada M, Isomoto S, Matsumoto S, et al. Sulphonylurea receptor 2B and Kir6.1 form a sulphony-lurea-sensitive but ATP-insensitive K+channel. J Physiol 1997; 499(Pt 3): 715-720.
94. Flagg TP, Enkvetchakul D, Koster JC, et al. Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev 2010; 90: 799-829.
95. Shi NQ, Ye B and Makielski JC. Function and distribution of the SUR isoforms and splice variants. J Mol Cell Cardiol 2005; 39: 51-60.
96. Teramoto N. Physiological roles of ATP-sensitive K+channels in smooth muscle. J Physiol 2006; 572(Pt 3): 617-624.
97. Ighodaro ET, Jicha GA, Schmitt FA, et al. Hippocampal sclerosis of aging can be segmental: two cases and review of the literature. J Neuropathol Exp Neurol 2015; 74: 642-652.
98. Nelson PT, Jicha GA, Wang WX, et al. ABCC9/SUR2 in the brain: implications for hippocampal sclerosis of aging and a potential therapeutic target. Ageing Res Rev 2015; 24(Pt B): 111-125.